BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6328146)

  • 1. Serotonergic stimulation of pituitary-adrenocortical activity in rats: evidence for multiple sites of action.
    Meyer JS; McElroy JF; Yehuda R; Miller J
    Life Sci; 1984 May; 34(20):1891-8. PubMed ID: 6328146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic stimulation of pituitary-adrenal activity in the mouse.
    Meyer JS; Buckholtz NS; Boggan WO
    Neuroendocrinology; 1978; 26(5):312-24. PubMed ID: 150549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin.
    Spinedi E; Gaillard RC
    J Endocrinol Invest; 1991; 14(7):551-7. PubMed ID: 1658112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
    Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
    Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and pituitary-adrenal function.
    Berger PA; Barchas JD; Vernikos-Danellis J
    Nature; 1974 Mar; 248(447):424-6. PubMed ID: 4363021
    [No Abstract]   [Full Text] [Related]  

  • 10. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the novel antidepressant tianeptine on L-5-hydroxytryptophan (5-HTP)-elicited corticosterone release and body weight loss.
    Broqua P; Baudrie V; Chaouloff F
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):115-20. PubMed ID: 1633432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of serotonin on the hypothalamic structures that participate in the regulation of the hypophyseal-adrenal cortex system].
    Maslova LN; Chernigovskaia EV; Belen'kiĭ MA; Danilova OA; Naumenko EV; Polenov AL
    Fiziol Zh SSSR Im I M Sechenova; 1990 Mar; 76(3):331-7. PubMed ID: 2164965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 5-hydroxytryptophan (5-HTP) in the regulation of the sleep/wake cycle in parachlorophenylalanine (p-CPA) pretreated rat: a multiple approach study.
    Touret M; Sarda N; Gharib A; Geffard M; Jouvet M
    Exp Brain Res; 1991; 86(1):117-24. PubMed ID: 1836762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site of action of 5-hydroxytryptophan and 5-hydroxytryptamine on the hypothalamo-pituitary-adrenal system in vitro.
    Telegdy G; Kardos M
    Acta Physiol Acad Sci Hung; 1975; 46(3):253-6. PubMed ID: 198221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative feedback of corticosterone on the pituitary-adrenal axis is maintained after inhibition of serotonin synthesis with parachlorophenylalanine.
    Armario A; Martí O; Gavaldà A
    Brain Res Bull; 1992 Jun; 28(6):915-8. PubMed ID: 1322230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats.
    Appel NM; Owens MJ; Culp S; Zaczek R; Contrera JF; Bissette G; Nemeroff CB; De Souza EB
    Endocrinology; 1991 Jun; 128(6):3237-46. PubMed ID: 1645265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic stimulation of pituitary-adrenocortical function in rats.
    Fuller RW
    Neuroendocrinology; 1981 Feb; 32(2):118-27. PubMed ID: 7010191
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.
    Van de Kar LD; Wilkinson CW; Ganong WF
    J Pharmacol Exp Ther; 1981 Oct; 219(1):85-90. PubMed ID: 6457138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds.
    Le Feuvre RA; Aisenthal L; Rothwell NJ
    Brain Res; 1991 Aug; 555(2):245-50. PubMed ID: 1933336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.